The Mid-Size Pharmaceuticals Global Market Report 2023, provides comprehensive information on the mid-size pharmaceuticals market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Mid-Size Pharmaceuticals Market’s Growth:
As per The Business Research Company’s Mid-Size Pharmaceuticals Global Market Report 2023, the market size is expected to grow from $632.95 billion in 2022 to $678.75 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of mid-size pharmaceuticals market is expected to reach $875.29 billion in 2027 at a CAGR of 6.5%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
Technology advancements are a key trend gaining popularity in the mid-size pharmaceuticals market. Major companies operating in the mid-size pharmaceuticals market are using technology to sustain their position in the market. For Instance, In May 2023, Google Cloud, offered by Google, a US-based suite of cloud computing services, launched A.I.-powered tools to accelerate drug discovery and precision medicine. One instrument, the Target and Lead Identification Suite assists businesses in foreseeing and comprehending protein structure, a crucial aspect of drug research. The Multiomics Suite is another tool that will help researchers in ingesting, storing, analyzing, and sharing vast volumes of genetic data.
The mid-size pharmaceuticals market is segmented:
1) By Drug Development Type: In-House, Outsource
2) By Type: Prescription, Over the Counter
3) By Formulation: Tablets, Capsules, Injectables, Sprays, Other Formulations
4) By Application: Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions
North America was the largest region in the mid-size pharmaceuticals market in 2022.
The table of contents in TBRC’s mid-size pharmaceuticals market report includes:
- Executive Summary
- Mid-Size Pharmaceuticals Market Characteristics
- Mid-Size Pharmaceuticals Market Trends And Strategies
- Mid-Size Pharmaceuticals Market – Macro Economic Scenario
- Mid-Size Pharmaceuticals Market Segmentation
- Global Mid-Size Pharmaceuticals Market Competitive Benchmarking
- Global Mid-Size Pharmaceuticals Market Competitive Dashboard
- Key Mergers And Acquisitions In The Mid-Size Pharmaceuticals Market
- Mid-Size Pharmaceuticals Market Future Outlook and Potential Analysis
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model